DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Terazosin Hydrochloride is a drug marketed by Apnar Pharma Lp, Beximco Pharms Usa, Heritage Pharma, Hikma, Jubilant Cadista, Mylan, Mylan Technologies, Ranbaxy Labs Ltd, Ivax Sub Teva Pharms, Sandoz, and Teva. and is included in twelve NDAs.
The generic ingredient in TERAZOSIN HYDROCHLORIDE is terazosin hydrochloride. There are twenty-four drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the terazosin hydrochloride profile page.
A generic version of TERAZOSIN HYDROCHLORIDE was approved as terazosin hydrochloride by APNAR PHARMA LP on March 30th, 1998.
Recent Clinical Trials for TERAZOSIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Qiang Zhang||Phase 1|
|University of Iowa||Phase 1|
|Michael J. Fox Foundation for Parkinson's Research||Phase 1|